Company: TDBCP
Filing Date: 2025-03-11
Form Type: 424B2
Source: 0001140361-25-007906
Chunk: 0

Company: TORONTO DOMINION BANK
Filing Date: 2025-03-11
Form: 424B2
Chunk 0
---
| Pricing Supplement dated March 7, 2025 to the        
 Product Supplement MLN-EI-1 dated February 26, 2025, 
 Underlier Supplement dated February 26, 2025 and     
 Prospectus dated February 26, 2025                   | Filed Pursuant to Rule 424(b)(2)      
 Registration Statement No. 333-283969 |

| The Toronto-Dominion Bank                
 $715,000                                 
 Capped Notes Linked to the S&P 500®Index 
 DueMarch 11, 2027                        
 Senior Debt Securities, Series H         |

General

| • | The Notes are designed for investors who (i) seek unleveraged exposure to a limited range of the percentage appreciation of the S&P 500®Index (the “Reference Asset”) from the Initial Level (as                                               
 defined below) to the Closing Level of the Reference Asset on the Valuation Date (the “Final Level”) and (ii) are willing to forgo interest and any dividend payments or other distributions on the stocks comprising the Reference Asset (the 
 “Reference Asset Constituents”).                                                                                                                                                                                                               |

| • | The Payment at Maturity will be greater than the Principal Amount only if the Final Level is greater than the Initial Level. Payment on the Notes is subject to our credit risk. |

Key Terms

| Issuer:              | The Toronto-Dominion Bank (“TD”)                                                                                                                                                                                                                                              |
| Reference Asset:     | The S&P 500®Index (Bloomberg ticker: SPX)                                                                                                                                                                                                                                     |
| Principal Amount:    | $1,000 per Note, subject to a minimum investment of $10,000 and integral multiples of $1,000 in excess thereof.                                                                                                                                                               |
| Term:                | Approximately 24 months.                                                                                                                                                                                                                                                      |
| Pricing Date:        | March 7, 2025                                                                                                                                                                                                                                                                 |
| Issue Date:          | March 12, 2025, which is three DTC settlement days following the Pricing Date.See “Supplemental Plan of                                                                                                                                                                       
 Distribution (Conflicts of Interest)” herein.                                                                                                                                                                                                                                 |
| Valuation Date:      | March 8, 2027, subject to postponement upon the occurrence of a market disruption event as described in the accompanying product supplement.                                                                                                                                  |
| Maturity Date:       | March 11, 2027, subject to postponement upon the occurrence of a market disruption event as described in the accompanying product supplement.                                                                                                                                 |
| Payment